IntraLinks Joins SAFE-BioPharma Association’s Vendor Partner Program

Collaboration to enable the use of digital signatures with secure document exchange

New York, March 26, 2007
IntraLinks, Inc., the leading provider of online workspaces for secure document exchange, announced today that it has joined the Vendor Partner program of SAFE-BioPharma Association, a non-profit association that created and manages the SAFE™ digital identity and signature standard for the pharmaceutical and healthcare industries.

For the past seven years, IntraLinks has worked closely with leading pharmaceutical and biotech companies to transition the document exchange component of the complete clinical trial management process from a paper-based to web-based environment. With the combined benefit of IntraLinks and the SAFE digital standard, investigator site personnel will be able to securely receive, complete, sign and submit critical clinical study documents electronically, accelerating the review process while avoiding the delays and risks associated with emailing, printing and shipping sensitive documents.

The SAFE standard provides a secure, legally enforceable, and regulatory compliant way to verify the identities of parties involved in business-to-business and business-to-regulator electronic transactions. Through the SAFE standard, SAFE promotes interoperability and integration among researchers, vendors, regulators, clinicians and other pharmaceutical and healthcare stakeholders.

“We are pleased to have IntraLinks as a new member of the SAFE community,” said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association. “Currently, managing clinical trials requires the complex exchange of thousands of pages of paper documents. Technologies that streamline these interactions and reduce paper are transforming the lifescience industry.”

“The demands of managing a steadily growing array of business partners and documents during clinical trials, product cross-licensing and other marketplace initiatives continue to grow more challenging for today’s biopharmaceutical organizations,” said David Espenshade, vice president for life sciences at IntraLinks. “Through this partnership, we will help biopharmaceutical professionals simplify compliance and security by enabling them to employ the SAFE standard to manage digital identities and signatures within a secure, globally accessible paperless operating environment.”

About IntraLinks
IntraLinks® On-Demand Workspaces™ connect business communities and accelerate the intelligent flow of information and documents among participants. Through IntraLinks' secure, neutral, online environments, companies are better able to compete globally by accelerating essential business processes, simplifying communication and fostering rapid workflow. IntraLinks is easily accessible anywhere, anytime using a web browser.

Since 1997, more than 600,000 participants representing over 50,000 organizations worldwide have used IntraLinks On-Demand Workspaces™ to communicate and collaborate on thousands of projects and transactions. IntraLinks has been adopted widely in the financial services and pharmaceutical industries, where its clients include AstraZeneca Pharmaceuticals LP, Bank of America, Bear Stearns, Deutsche Bank, FDIC, TD Securities, Thomas Weisel Partners and WestLB, among hundreds of others. Founded in 1996, IntraLinks is headquartered in New York with offices around the world.

About SAFE-BioPharma Association
SAFE-BioPharma Association is the non-profit association that created and manages the SAFE™ digital identity and digital signature standard for the pharmaceutical and healthcare industries. Through the SAFE standard, the association promotes interoperability and integration among researchers, vendors, regulators, clinicians and other pharmaceutical and healthcare stakeholders. The SAFE standard provides a secure, enforceable, and regulatory compliant way to verify the identities of parties involved in business-to-business and business-to-regulator electronic transactions. SAFE stands for “Signatures and Authentication For Everyone.” The Association’s founder-members include AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer, Procter & Gamble, and Sanofi-Aventis. For more information visit www.safe-biopharma.org.